HomeNewsTrendsExpert ColumnsA new worry for India’s airlines — planes ready to be delivered

A new worry for India’s airlines — planes ready to be delivered

The move by some airlines from India to place record orders with Airbus and Boeing will now haunt them because the coronovirus pandemic has severely impacted passenger demand.

June 10, 2020 / 13:50 IST
Story continues below Advertisement
(Image: News18)
(Image: News18)

The decision of IndiGo, India’s largest airline, last week that it would continue to take delivery of new aircraft and balance it by returning the older A320ceo despite the current situation, raised many eyebrows. Air traffic has plummeted to new lows and recovery isn’t in sight yet, but IndiGo is trying hard to keep costs low.

From grounding of over 650 aircraft on March 25 to excess planes with airlines currently, airlines have come a long way in two months.

Story continues below Advertisement

The move by some airlines from India to place record orders with both Airbus and Boeing will now haunt them because of the coronavirus lockdown. IndiGo, GoAir, Vistara and Spicejet have aircraft on order with Airbus and Boeing. While Air India does not have any aircraft on order, AirAsia India has not placed any order with any manufacturer directly with all its aircraft leased, a few coming in from its parent in Malaysia and other group subsidiaries and the rest coming in from open market lease.

IndiGo has 332 A320neo on order along with 398 A321neo, some of which are the A321XLR – which is yet to have its first flight. With over 100 A320neos already in fleet and 17 A321neo in fleet, the airline has a backlog of 600+ aircraft. The Wadias-backed Go Air had ordered 144 A320neos in two tranches of which the airline has taken delivery of 43 aircraft, with a hundred more yet to be delivered.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show